Literature DB >> 28953714

Discussion: Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand: High-Surface-Area Textured Implants Are Associated with Increased Risk.

Mark W Clemens1,2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28953714     DOI： 10.1097/PRS.0000000000003714

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN： 0032-1052            Impact factor:   4.730


× No keyword cloud information.
  5 in total

1.  The Cellular Origins of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Implications for Immunogenesis.

Authors:  Suzanne Dawn Turner
Journal:  Aesthet Surg J       Date:  2019-01-31       Impact factor: 4.283

2.  Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants.

Authors:  Peter G Cordeiro; Paola Ghione; Andy Ni; Qunying Hu; Nivetha Ganesan; Natasha Galasso; Ahmet Dogan; Steven M Horwitz
Journal:  J Plast Reconstr Aesthet Surg       Date:  2020-01-20       Impact factor: 2.740

3.  How I treat breast implant-associated anaplastic large cell lymphoma.

Authors:  Neha Mehta-Shah; Mark W Clemens; Steven M Horwitz
Journal:  Blood       Date:  2018-09-12       Impact factor: 22.113

Review 4.  Breast implant-associated anaplastic large cell lymphoma: a review.

Authors:  Andrés E Quesada; L Jeffrey Medeiros; Mark W Clemens; Maria C Ferrufino-Schmidt; Sergio Pina-Oviedo; Roberto N Miranda
Journal:  Mod Pathol       Date:  2018-09-11       Impact factor: 7.842

5.  Breast Implant-associated Anaplastic Large Cell Lymphoma Incidence: Determining an Accurate Risk.

Authors:  Jonas A Nelson; Stefan Dabic; Babak J Mehrara; Peter G Cordeiro; Joseph J Disa; Andrea L Pusic; Evan Matros; Joseph H Dayan; Robert J Allen; Michelle Coriddi; Thais O Polanco; Meghana G Shamsunder; Itay Wiser; Monica Morrow; Ahmet Dogan; Michele R Cavalli; Elizabeth Encarnacion; Meghan E Lee; Colleen M McCarthy
Journal:  Ann Surg       Date:  2020-09-01       Impact factor: 12.969
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.